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Abstract
The prevailing paradigm of T lymphocyte control of viral replication is that the protective capacity of virus-specific CD8
+ T
cells is directly proportional to the number of functions they can perform, with IL-2 production capacity considered critical.
Having recently defined rapid perforin upregulation as a novel effector function of antigen-specific CD8
+ T cells, here we
sought to determine whether new perforin production is a component of polyfunctional CD8
+ T cell responses that
contributes to the control of several human viral infections: cytomegalovirus (CMV), Epstein-Barr virus (EBV), influenza (flu),
and adenovirus (Ad). We stimulated normal human donor PBMC with synthetic peptides whose amino acid sequences
correspond to defined CTL epitopes in the aforementioned viruses, and then used polychromatic flow cytometry to
measure the functional capacity and the phenotype of the responding CD8
+ T cells. While EBV and flu-specific CD8
+ T cells
rarely upregulate perforin, CMV-specific cells often do and Ad stimulates an exceptionally strong perforin response. The
differential propensity of CD8
+ T cells to produce either IL-2 or perforin is in part related to levels of CD28 and the
transcription factor T-bet, as CD8
+ T cells that rapidly upregulate perforin harbor high levels of T-bet and those producing
IL-2 express high amounts of CD28. Thus, ‘‘polyfunctional’’ profiling of antigen-specific CD8
+ T cells must not be limited to
simply the number of functions the cell can perform, or one particular memory phenotype, but should actually define which
combinations of memory markers and functions are relevant in each pathogenic context.
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Introduction
Understanding the mechanisms by which human T cells
provide effective control of pathogens is important for designing
interventions against those that persist to cause severe morbidity
and/or mortality. T cells generally limit the replication of Epstein
Barr virus (EBV)[1,2], Cytomegalovirus (CMV)[3,4,5], and
Hepatitis viruses B[6,7,8] and C[9,10], but only rarely of the
Human Immunodeficiency Virus (HIV), as the majority of HIV
infections inevitably result in progressive disease. Cytotoxic T
lymphocytes (CTL) are thought to be a primary mediator of viral
control, due in large part to their ability to recognize and eliminate
virally infected autologous cells. Although CD8
+ T cells respond to
viral infection with a plethora of effector functions, the
identification of a definite immune correlate of protection has
not been forthcoming for any human pathogen.
Recent strategies of assessing human antiviral T cell responses
focus on the quality of the T cell response, defined by its
polyfunctional nature. Briefly, the more effector functions that
constitute the overall response, the more protective the response is
considered[11,12]. Typically, the functions quantified simulta-
neously include upregulation of interferon gamma (IFN-c) and
interleukin-2 (IL-2)[13,14,15]. A more elaborate assessment of the
T cell response may include a measurement of tumour necrosis
factor alpha (TNF-a), a chemokine such as MIP-1b, and
degranulation measured by CD107a exposure. A high frequency,
multi-functional CD4
+ T cell response composed of IFN-c, IL-2,
and TNF-a provides protection against Leishmania major
infection in mice[16], however a similar correlation in humans
for antiviral CD8
+ T cells has not been formally proven. This is
likely because none, or any combination, of these functions may
directly inhibit pathogen replication.
CTL clear virally infected target cells primarily via the
exocytosis of cytotoxic granules containing granzymes and
perforin[17,18,19,20]. The manifestations of genetic mutation or
deletion of perforin are impaired cellular cytotoxicity and
profound immunodeficiency[21,22]. We have recently shown that
human CD8
+ T cells can rapidly upregulate perforin de novo after
antigen-specific stimulation[23], which is immediately transported
to the immunological synapse where it likely potentiates
cytotoxicity[24]. The measurement of new perforin is different
from that of pre-formed perforin stored in cytotoxic granules, in
that it indicates the potential of the cell to rapidly reconstitute its
cytotoxic nature. In contrast, the assessment of pre-formed
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does not predict the sustainability of the cytotoxic response. Thus,
analyzing this novel aspect of T cell functionality could provide
new insight into how CD8
+ T cells mediate pathogenic control.
Here we examine perforin upregulation ability in the context of
polyfunctional CD8
+ T cell responses to several common human
viral pathogens: Cytomegalovirus (CMV), Epstein-Barr virus
(EBV), Adenovirus (Ad), or Influenza (flu). Infection by EBV,
CMV, flu, or Ad stimulates robust memory T cell responses that
are associated with protection from viral pathogenesis. However,
each course of infection is different: CMV establishes latency but
remains lytically active, thereby creating a constant supply of
antigen to the immune system, whereas EBV enters the lytic phase
infrequently after establishing latency. Thus, EBV-specific CD8
+
T cells likely only receive periodic restimulation. Primary Ad and
flu infections are quickly resolved by the host immune response,
but since Ad may become persistent, and there are many Ad
serotypes whose sequences are highly conserved[25,26], Ad-
specific CD8
+ T cells are likely repeatedly stimulated. In contrast,
flu infections are seasonal and readily cleared, thus flu-specific
CD8
+ T cell restimulation is likely more intermittent than that for
other viruses. We show that the measurement of perforin
upregulation redefines our interpretation of polyfunctional CD8
+
T cell responses and memory phenotypes that we associate with
control of these pathogens, and represents a novel correlate of
antiviral immunity that should be considered in assessments of
human antiviral CD8
+ T cell responses.
Results
We assayed 23 normal donors for memory CD8
+ T cell
responses against CMV, EBV, Ad, or flu, as defined by the ability
to upregulate IFN-c, TNF-a, IL-2, and/or perforin, or to
degranulate, in response to stimulation with individual or pools
of synthetic peptides that represent defined CTL epitope(s) in the
amino acid sequence of the corresponding virus (Table 1).
Individual peptide stimuli were determined by prior epitope
mapping experiments, whereas pools of peptides were used on
subjects for whom specific epitopes were not identified. We used
IFN-c production as a basal readout of activation; as shown in
Figure 1A, we were able to detect CD8
+ T cell responses against at
least one viral peptide or peptide pool in each of the 23 donors.
Two individuals did not produce IFN-c in response to peptide
stimulation (1 EBV, 1 flu) but instead produced TNF-a and/or IL-
2 (data not shown). The largest virus specific responses we noted
were CMV- or EBV-specific, with some individuals exhibiting
responses up to ,5% of total CD8
+ T cells against a single epitope
[median (black bar on Figure 1A) CMV=0.28%, median
EBV=0.40%]. Ad-specific responses were found up to ,1% of
total CD8
+ T cells against pools of hexon or E1A-derived peptides
Author Summary
Although CD8
+ T cells are thought to be largely
responsible for the control of viral infections, exactly how
they mediate protection is uncertain. One approach to
assessing their protective capacity is to measure several of
their functions simultaneously. Generally, it is believed the
more functions a cell can perform, the better its potential
to control viral replication. A multi-functional response
including interleukin-2 (IL-2) production is currently valued
as the key correlate of protection. We recently character-
ized a novel CD8
+ T cell function: rapid perforin upregula-
tion, which serves to contribute to and sustain the killing
of virally infected host cells. In this study, we show that
new perforin is abundant during adenovirus and cyto-
megalovirus infections, but scarcely detected in the
context of influenza and Epstein-Barr virus. Importantly,
perforin and IL-2 are rarely co-expressed. The significance
of this relationship is that we can no longer assume the
more functions a CD8
+ T cell performs in response to a
virus the better. Thus, when considering vaccine design,
no single functional profile will likely be protective across
all pathogens. Rather, vaccine-induced T cell responses
may need to be ‘‘pathogen-specific’’, as different T cell
functional responses will be important for controlling
different viral infections.
Table 1. Peptides used as stimuli for each subject.
Subject Stimulus Amino Acid Sequence
A CMV (pp65) SDEEEAIVAYTL
CMV (pp65) TPRVTGGGAM
B CMV (pp65) NLVPMVATV
CMV (pp65) IPSINVHHY
C EBV (BMLF1) GLCTLVAML
CMV (pp65) NLVPMVATV
CMV (pp65) RKTPRVTGGGAMAGA
D CMV (pool) 37 peptides
E CMV (pp65) RKTPRVTGGGAMAGA
F Flu (NP) RIAYERMCNILKGKF
G Flu (NP) IRPNENPAHKSQLVM
H Flu (Matrix 1) GILGFVFTL
I Flu (NP) RASVGKMIGGIGRFY
J Flu (Matrix 1) AVKLYRKLKREITFH
K Flu (NP) RIAYERMCNILKGKF
L Flu (Matrix 1) TKGILGFVFTLTVPS
M Ad Hu5 Hexon (CR1 pool) 43 peptides
Ad Hu5 Hexon (CR2 pool) 41 peptides
Ad Hu5 Hexon (CR3 pool) 49 peptides
N Ad Hu5 Hexon (CR2 pool) 41 peptides
O Ad Hu5 Hexon (CR2 pool) 41 peptides
P Ad Hu5 Hexon (CR1 pool) 43 peptides
Ad Hu5 Hexon (CR2 pool) 41 peptides
Ad Hu5 Hexon (CR3 pool) 49 peptides
Q Ad Hu5 Hexon (CR2 pool) 41 peptides
R Ad Hu5 E1a (pool) 46 peptides
Ad Hu5 Hexon (VR pool) 36 peptides
S EBV (BZLF1) RAKFKQLL
T CMV (pp65) RKTPRVTGGGAMAGA
EBV (EBNA3A) RPPIFIRRL
U Flu (NP) ELRSRYWAI
EBV (BZLF1) RAKFKQLL
V Flu (Matrix 1) GILGFVFTL
EBV (EBNA3A) YPLHEQHGM
CMV (pp65) NLVPMVATV
W EBV (BZLF1) RAKFKQLL
EBV (EBNA3A) FLRGRAYGL
EBV (EBNA3A) QAKWRLQTL
doi:10.1371/journal.ppat.1000798.t001
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lower magnitude than that for other viruses (median flu=0.029%).
Despite the low magnitude, flu-specific IFN-c responses were
readily detectable (Figure 1B). All subjects produced strong CD8
+
T cell IFN-c responses after SEB stimulation (Figure 1A,
median=2.76%).
IFN-c producing virus-specific CD8
+ T cells differentially
express other functions
While IFN-c production is commonly measured to identify
virus-specific CD8
+ T cells, it is unclear whether or not it
represents a true correlate of immune protection for EBV, CMV,
flu, or Ad. We therefore assessed the capacity of IFN-c producing
CD8
+ T cells to perform other functions which might be
associated with viral control, including rapid perforin upregula-
tion, TNF-a, IL-2, and degranulation.
We recently characterized rapid perforin upregulation as a
novel function of antigen-specific CD8
+ T cells[24], the measure-
ment of which indicates the cells’ potential to sustain cytotoxicity.
Briefly, newly produced perforin can be detected by a specific anti-
perforin antibody (clone D48) which recognizes both pre-formed
perforin stored in cytotoxic granules as well as new perforin that
has been rapidly produced in response to antigenic stimulation. In
contrast, a second perforin antibody (clone dG9) primarily
recognizes perforin within cytotoxic granules. By quantifying
perforin with the D48 antibody together with another function
such as IFN-c, it is possible to discriminate new perforin from pre-
formed granule-associated perforin in activated CD8
+ T cells. As
shown in Figure 2A (top row), the activated cells that produced
IFN-c but failed to degranulate possessed the most perforin (Q3,
green). Activated CD8
+ T cells that both degranulated and
upregulated IFN-c harbored an intermediate amount of perforin
(Q2, blue). Perforin was essentially absent in degranulating cells
that failed to also produce IFN-c (Q1, red). The Q1 and Q2
populations were both degranulating to the same degree, yet they
represent responding cells that differentially upregulate perforin
production. This may simply be an issue of kinetics, in that the
cells that only degranulate may not have yet upregulated perforin,
or signify a truly separate subpopulation that cannot upregulate
perforin. Similarly, the IFN-c producing responder population
(Q2 and Q3) is divided into distinct functional (perforin 6
CD107a) subsets. In contrast, the dG9 antibody, specific only for
granule-associated perforin, failed to detect perforin in any of the
functional subpopulations (Figure 2A, bottom row). Together,
these data indicate that antigen-specific human CD8
+ T cells are
capable of upregulating perforin rapidly after stimulation, in the
absence of cellular proliferation, and without the addition of
exogenous cytokines or other co-factors.
We next examined whether rapid perforin upregulation was
characteristic of EBV, CMV, flu, and Ad-specific CD8
+ Tc e l l
Figure 1. IFN-c production as a basal marker of activation for antiviral CD8
+ T cells. (A) IFN-c production in response to viral peptides. Cells
from 23 normal human donors (symbols for each donor are listed in the legend) to produce IFN-c in response to stimulation with peptide antigens from
four different viruses: cytomegalovirus (CMV), Epstein-Barr virus (EBV), Adenovirus (Ad), and influenza (Flu). The responses are grouped by viral
specificity: CMV in red, EBV in blue, Ad in orange, and flu in black. The superantigen Staphylococcus Enterotoxin B (SEB) was used as a positive control
(greensymbols). Some subjects were screened with more than one stimulus (see Table 1). For example, subjectC was stimulated with 3 peptides, hence
3 open circles on the graph. The black horizontal bars indicate the median response in each group. (B) A representative CD8
+ T cell IFN-c response, after
stimulation with flu peptide 64 in Donor G. Unstimulated (NS) and SEB-stimulated cells are shown as negative and positive controls, respectively.
doi:10.1371/journal.ppat.1000798.g001
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of every antigen-specific IFN-c response also upregulated perforin in
each donor. A representative example is shown in Figure 2B (left
panel), where 87.2% of the IFN-c producing cells concomitantly
upregulated perforin. The cohort results are illustrated in the right
panel of Figure 2B. Whereas nearly all IFN-c
+ Ad-specific CD8
+ T
cells upregulated perforin [orange group, median (black
bar)=73.6%], those responding to EBV and flu displayed limited
perforin upregulation [blue group, median=4.95% and black group,
median=0%, respectively]. Only donor U mounted a substantial
EBV-specific perforin response (58.3% of the IFN-c
+ CD8
+ Tc e l l s ) .
CMV-specific perforin upregulation was highly variable between
subjects [red group, median (black bar)=25.1%, range: 5.39%–
78.0%]; while some donors exhibited strong perforin upregulation
(donors D=78.0% and E=60.9%), others were more limited [donor
B, red open diamond: CMV peptide 20=5.39%, CMV peptide
23=12.8%]. Polyclonal SEB stimulation also resulted in varying
degrees of perforin responsiveness [green group, median=26.0%,
range: 1.02%–62.8%]. Thus, immediate perforin upregulation is not
an effector function common to all antigen-specific CD8
+ T cells;
rather it seems to be characteristic of CD8
+ T cells specific for
particular viral infections.
Since perforin is typically expressed with other cytotoxic
proteins[19,27,28], we assayed for concomitant granzyme B and
perforin upregulation in response to SEB stimulation in a small
cohort of normal PBMC donors. As depicted in Figure 2C,
perforin and granzyme B upregulation are tightly linked functions
of responsive CD8
+ T cells [r=0.9135, 95% C.I.=0.5861 to
0.9845, two tailed p value=0.0015; Pearson correlation]. Thus, it
is reasonable to infer CD8
+ T cells that upregulate perforin are
also producing new granzyme B.
Next, we examined the capacity of virus-specific IFN-c
+ CD8
+
T cells to also produce IL-2 (Figure 3A). In contrast to perforin,
IL-2 production was elevated in EBV- and flu-specific CD8
+ T
cells [EBV: blue group, median=71.7%, flu: black group,
median=55.7%, respectively], whereas in CMV and Ad it was
much lower [CMV: red group, median (black bar)=39.4%, Ad:
orange group, median=0.21%, respectively].
Finally, we analyzed degranulation capacity using the lysosomal
and granule resident marker CD107a[29,30], as well as TNF-a
production [Figure 2B and 2C, respectively]. The CD107a
Figure 2. Perforin upregulation by CD8
+ T cells after peptide-
specific activation. (A) Detection of Donor E perforin upregulation
in the context of degranulation and IFN-c production. The dot plots in
the left panels define the IFN-c and CD107a functional subsets
(Quadrants 1–3), while the histograms on the right illustrate the
p e r f o r i nc o n t e n to fe a c hf u n c t i o n a ls u b s e t .T h ec e l l ss h o w ni nt h et o p
row were stained with the anti-perforin antibody clone D48, whereas
those in the bottom row were stained with the dG9 perforin antibody.
The histograms depict the perforin content of the corresponding
quadrants, as matched by colour. For example, the red histogram
represents the perforin content of Quadrant 1 (Q1), defined by the red
box on the dot plot. (B) A representative example of perforin
upregulation by IFN-c producing CD8
+ T cells, in response to Ad
Hu5 peptide C3 is shown in the left panel. The value in red represents
the proportion of IFN-c producing CD8
+ T cells that also produce
perforin, whereas the black quadrant numbers reflect the proportion
of total CD8
+ T cells producing the given function. NS= no
stimulation. The right panel illustrates perforin upregulation in IFN-
c
+ CD8
+ T cells after activation with peptides from CMV (red), EBV
(blue), Ad (orange), and flu (black) by the cohort. Individual symbols
represent different subjects (see Figure 1). The black horizontal bars
i n d i c a t et h em e d i a nr e s p o n s ei ne a c hg r o u p .( C )P e r f o r i na n d
granzyme B are co-expressed in activated CD8
+ T cells. The proportion
of CD8
+ T cells making new perforin in response to SEB stimulation
was plotted against that of CD8
+ T cells making granzyme B for 8
subjects. The values for both granzyme B and perforin represent cells
that were first defined as IFN-c
+. The significance of the relationship
was determined by calculating the Pearson product-moment corre-
lation coefficient, r.
doi:10.1371/journal.ppat.1000798.g002
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perforin: CMV and Ad stimuli induced strong CD8
+ T cell
degranulation [Figure 2B; CMV: red group, median (black
bar)=65.05%, Ad: orange group, median=87.2%], whereas
EBV and flu did to a lesser extent [EBV: blue group,
median=37.2%, flu: black group, median=25.8%]. Unlike both
CD107a and perforin, TNF-a production was ubiquitously
expressed, as nearly every virus-specific IFN-c
+ CD8
+ T cell also
produced TNF-a [Figure 2C; CMV: red group, median (black
bar)=94.6%; EBV: blue group, median (black bar)=91.35%; Ad:
orange group, median (black bar)=83.0%; flu: black group,
median (black bar)=84.6%].
Taken together, these results suggest that there are substantially
different CD8
+T cellfunctionalprofilesagainstCMV,EBV,Ad,and
flu, and that no single function (or pair of functions) likely defines a
universal correlate of immune protection for all of these viruses.
Polyfunctional profiles of virus-specific CD8
+ T cell
responses
We next characterized the polyfunctionality of the virus-specific
CD8
+ T cells from each donor to see if a particular response
profile(s) was consistently detected in all viral contexts. We
grouped donor responses according to viral specificity, and then
assessed the average CD8
+ T cell polyfunctional profile specific for
that viral infection. As shown in Figure 4A, each viral antigen
stimulated a unique functional profile consisting of varying degrees
of polyfunctionality. Perforin production (designated by purple
arcs around the pies) dominated the Ad-specific response profile
Figure 3. Individual CD8
+ T cell functions do not predict universal viral control. IFN-c producing virus-specific CD8
+ T cells differentially
upregulate IL-2 (A), degranulation (B), and TNF-a (C). The graphs (left panels) summarize the responses, stratified by virus: CMV responders represented
in red, EBV in blue, Ad in orange, and flu in black. The black horizontal bars indicate the median response in each group. Representative staining results
for each individual function are shown to the right of the graphs. Each function was quantified against IFN-c to permit comparative analysis. The red
number in each plot represents the proportion of IFN-c producing CD8
+ T cells that also produce that function, whereas the black numbers reflect the
proportion of total CD8
+ T cells that upregulate that function. NS= no stimulation. Individual subject symbols are as described in Figure 1.
doi:10.1371/journal.ppat.1000798.g003
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in a 4+ population (orange pie slice) together with CD107a, IFN-c,
and TNF-a. In the case of CMV, perforin upregulation was
somewhat less dominant, but was similarly co-expressed with
CD107a, IFN-c, and TNF-a (Figure 4B) to form a substantial 4+
population (Figure 4A, orange pie slice). EBV also generated a
highly multi-functional response, however the 4+ population
(orange pie slice) was composed entirely of an IL-2
+CD107a
+IFN-
c
+TNF-a
+ CD8
+ T cell subset (Figure 4B). IL-2 production also
dominated the 4+ polyfunctional profile of flu, as the IL-
2
+CD107a
+IFN-c
+TNF-a
+ subset was again the principal multi-
functional population (Figure 4B). In fact, as depicted by the arcs
around the pies in Figure 4A, it appears that IL-2 production
(black arcs) and perforin upregulation (purple arcs) generally are
not co-expressed within any polyfunctional population. Thus,
while every virus stimulated a high frequency of CD8
+ T cells
capable of four effector functions simultaneously, CMV and Ad
induced a perforin driven 4+ responder population, whereas EBV
and flu preferentially stimulated an IL-2 dominated 4+ subset.
An inverse relationship exists between perforin and IL-2
upregulation
Strikingly, none of the virus-specific CD8
+ T cell response profiles
included a 5+ subset, suggesting that responding CD8
+ T cells rarely
upregulate perforin and IL-2 simultaneously. To further explore this
possibility, we plotted the proportion of antigen-specific IFN-c
+ cells
producing either new perforin or IL-2. As depicted in Figure 5A, a
statistically significant inverse correlation exists between IL-2 and
perforin positivity in virus-specific IFN-c
+ CD8
+ T cells (r=20.5684,
95% C.I.=20.7604 to 20.2849, p,0.0005; Pearson correlation). A
strong correlation also results if only SEB-induced responses are
considered (Figure 5B; r=20.6011, 95% C.I.=20.8244 to 20.2159,
p,0.0051; Pearson correlation). We performed our analysis on total
CD8
+ Tc e l l s ,e v e nt h o u g hn a ı ¨ve cells preferentially produce IL-2 over
IFN-c and perforin. In our data set, however, the contribution of IL-2
from naı ¨ve CD8
+ T cells in response to SEB stimulation is minimal
compared to the antigen-experienced cells (not shown), and does not
change the relationship we observe between IL-2 and perforin.
Thus, although not absolute, simultaneous production of IL-2
and perforin within the same CD8
+ T cell, or within a virus-
specific CD8
+ T cell population, is exceptionally rare, suggesting a
mutually exclusive relationship between these functions.
The transcription factor T-bet preferentially accumulates
in CD8
+ T cells that rapidly upregulate perforin while
those producing IL-2 express CD28
There are several precedents characterizing the functional
attributes of particular CD8
+ T cell memory phenotypes in the
Figure 4. Rapid perforin upregulation and IL-2 production define distinct functional subsets for each model virus. (A) Average
functional response profile of the 23 donors, symbolized as a pie chart, and stratified by virus. PBMC from each subject were simultaneously assayed
for perforin, IFN-c, IL-2, TNF-a, and CD107a upregulation. Pie slices represent the proportion of responding CD8
+ T cells that upregulated all 5 (red), 4
(orange), 3 (yellow), 2 (green) and 1 (blue) function(s). Purple arcs denote the proportion of the responses that include perforin upregulation; black
arcs denote responses that upregulate IL-2. (B) Distribution of responding CD8
+ T cells across 16 different functional subsets. Possible functional
combinations that were not observed are omitted for clarity. EBV responses are illustrated with blue bars, flu responses with black bars, CMV
responses with red bars, Ad responses with orange bars, and SEB responses with green bars. P = Perforin, 2=IL-2, 7=CD107a, G = IFN-c, T = TNF-a.
The y-axis denotes the proportion of the total CD8
+ T cell response to the given virus that produces a specific profile of functions.
doi:10.1371/journal.ppat.1000798.g004
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for these differences remains unknown. We investigated the
potential role of two cellular factors in determining the preferential
expression of either perforin or IL-2 by virus-specific human
effector CD8
+ T cells: CD28, a co-receptor whose signaling is
critical for the induction of IL-2 production[35,36], and T-bet, the
T-box transcription factor associated with effector func-
tion[37,38,39]. As illustrated in Figure 6A, CD28 is commonly
detected on IL-2 producing CD8
+ T cells (mean=65.4%,
SEM=6.125, 95% C.I. 52.2–78.5%), whereas its expression is
significantly lower on those upregulating perforin (mean=19.7%,
SEM=5.047, 95% C.I 8.85–30.5%; p=,0.0001, Paired t-test).
Within all subjects tested (each represented by a unique symbol),
CD28 expression was always higher on the antigen-specific CD8
+
T cells (each stimuli represented by a unique colour) producing IL-
2 than their counterparts upregulating perforin (Figure 6A). A
phenotypic evaluation of IL-2 producing and perforin upregulat-
ing cells reveals that the former cells bear relatively high levels of
CD27 and CD28 but low levels of CD57, whereas the latter cells
are mostly CD27
+/2CD28
loCD57
hi (Supplementary Figure S1).
Thus, CD28, which is important mechanistically for IL-2
production, is not commonly detected on CD8
+ T cells that are
rapidly upregulating perforin.
Although T-bet has been linked to the development of TH1
responses and effector function in murine CD4
+ and CD8
+ T
cells, respectively[38,39], a similar relationship has yet to be
formally demonstrated in humans.The only possible exception is
a clinical study of ICOS-deficient sibling patients in whom
impaired CD8
+ T cell effector function and decreased develop-
ment of memory T cell populations was indirectly linked to T-bet
[40]. As illustrated in Figure 6B, we first examined the levels of
T-bet in resting human CD8
+ T cell memory subsets directly ex
vivo. Effector cells (CCR7
2CD45RO
2), and to a lesser degree
effector memory cells (CCR7
2CD45RO
+), exhibited concor-
dant levels of perforin and T-bet, whereas both factors were
absent in naı ¨ve (CCR7
+CD45RO
2) and central memory cells
(CCR7
+CD45RO
+). We then stimulated the PBMC from the
same donor with SEB to activate all the functional subsets and
assessed T-bet expression in the fraction of CD8
+ T cells that
rapidly upregulates perforin, compared to that producing IL-2
(Figure 6C). T-bet expression was most pronounced in perforin-
producing cells compared to both IL-2 producing cells and naı ¨ve
CD8
+ T cells, although IL-2 producing cells did harbor more T-
bet than naı ¨ve CD8
+ T cells. Overall, in 6 separate individuals
we observed T-bet in a higher proportion of CD8
+ T cells
upregulating perforin than in those producing IL-2 (Figure
6D: median=91.75% vs. 58.1%, mean=89.0567.77% vs.
57.25620.93%, p=0.0068, Paired t-test). Furthermore, CD8
+
T cells that rapidly upregulate perforin express more T-bet on a
per cell basis than those that produce IL-2 (Figure 6E:
median=1476 vs. 893.5, mean=14916205.9 vs. 967.26248.7
median fluorescence intensity, p=0.004, Paired t-test).
In conclusion, the preferential expression of the transcription
factor T-bet in CD8
+ T cells that rapidly upregulate perforin over
those that produce IL-2 supports a significant role for T-bet in the
differentiation of antigen-specific human CD8
+ T cells into
cytotoxic effector cells. Furthermore, the expression of CD28 co-
receptor is correlated to IL-2 production.
Discussion
What defines the ‘‘optimal’’ CD8
+ T cell polyfunctional profile
for viral infections in humans? The data we have presented here
suggest that based upon the characteristics of replication, latency,
persistence, and antigen load, every virus will potentially stimulate
multiple polyfunctional profiles distinct from those of other viral
infections. Here we examined four different viral infections, each
of which is controlled or eliminated at least in part by viral-specific
CD8
+ T cells, and for each of these viral specificities we have
found unique polyfunctional profiles. At the simplest level, it
appears that rapid perforin upregulation and IL-2 production
define complementary functional CD8
+ T cell subsets that bear
unique phenotypic profiles and predominate according to
antigenic burden.
It has long been appreciated that CD8
+ T cells play a pivotal
role in the direct elimination of virally infected cells, and that
perforin is a key mediator of this process through its distinct ability
to enable the entry of apoptosis-inducing granzymes[17,20]. We
previously demonstrated that virus-specific CD8
+ T cells rapidly
upregulate perforin after activation and then target the protein
directly to the interface between the CTL and its target[24]. This
sustained production and targeted release of new perforin after
stimulation may allow the CD8
+ T cell to recognize and kill
Figure 5. Rapid perforin upregulation and IL-2 production are
inversely correlated functions of virus-specific CD8
+ T cells. (A)
The proportion of antigen-specific IFN-c
+ CD8
+ T cells making new
perforin was plotted against that of IFN-c
+ CD8
+ T cells making IL-2.
Responses from all donors for every virus were included. Individual
symbols represent individual donors. CMV responses are shown in red,
EBV in blue, Ad in orange, and flu in black. (B) Perforin
+ IFN-c
+ or IL-2
+
IFN-c
+ SEB-induced responses from each donor were plotted. The
significance of the relationship was determined by calculating the
Pearson product-moment correlation coefficient, r.
doi:10.1371/journal.ppat.1000798.g005
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formed perforin stored in cytotoxic granules. The measurement of
new perforin production is significant because it serves as a gauge
of a CD8
+ T cells’ potential to repeatedly eliminate infected host
cells and, hence, control viral pathogenesis. Here we show that
rapid perforin upregulation is a highly specialized ability not
common to all CD8
+ T cells. Rather, it appears to be tied to the
antigenic history of the cell.
Whereas perforin upregulation and degranulation are com-
monly associated functions of CTL, there appears to be a mutually
exclusive relationship between new perforin and IL-2 upregula-
tion. Rapid perforin upregulation ability is not commonly
observed against influenza and EBV. The fact that these
pathogens establish latency (EBV) or are rapidly cleared (flu)
suggests that antigen load or continual antigen exposure may in
part maintain perforin upregulation ability and drive effector
phenotype differentiation. For these viruses, proliferation and/or
consequent differentiation of the EBV and flu-specific memory
CD8
+ T cells may be necessary to induce perforin upregulation. In
contrast, perforin upregulation is more prominent in response to
CMV and Adenovirus. CMV infection is characterized by
continual low-level viral replication, and can induce massive
expansions of CMV-specific effector CD8
+ T cells[41]. Hence, it is
not entirely surprising that CMV-specific CD8
+ T cells should be
capable of rapid perforin upregulation. The potent ability of Ad-
specific CD8
+ T cells to upregulate perforin, on the other hand,
was unexpected since Ad, much like flu, should be rapidly cleared.
However, there is evidence that Ad can become persistent[42].
Furthermore, there are at least 51 different Ad serotypes in
circulation around the world, with differential levels of neutralizing
antibodies against each serotype being present within a given
individual[43]. As there is a high degree of sequence conservation
between various Ad serotypes[26], cross-reactive CD8
+ T cells are
quite common, even between distantly related Ad serotypes[25].
Therefore, it is likely that exposure to Ad antigen from persisting
virus or exposure to different Ad serotypes repeatedly activates Ad-
Figure 6. T-bet is preferentially expressed in CD8
+ T cells that rapidly upregulate perforin and promotes an effector phenotype. (A)
Proportion of perforin
+ (right) and IL2
+ (left) CD8
+ T cells that express CD28. Observations are paired; PBMC from every subject (designated by a
unique symbol) were activated using peptide stimuli (coloured) and SEB (green symbols). Statistical differences were determined by a Paired t test,
two-tailed, t=8.631, df=14. (B) Levels of T-bet and perforin expression in resting naı ¨ve cells (N, CCR7
+CD45RO
2; upper left plot), central memory cells
(CM, CCR7
+CD45RO
+; upper right plot), effector memory cells (EM, CCR7
2CD45RO
+; lower right plot), and effector cells (E, CCR7
2CD45RO
2; lower left
plot). (C) Relative expression of T-bet in naı ¨ve (black line), IL-2 producing (blue line), and perforin upregulating (red line) CD8
+ T cells stimulated with
SEB. (D) Proportion of CD8
+perforin
+ (right, square symbols) and CD8
+IL2
+ (left, circle symbols) T cells that also express T-bet upon stimulation with
SEB. Observations are paired and colour-coded by subject. Statistical difference determined by a Paired t test, two-tailed, t=4.427, df=5. (E)
Abundance of T-bet on a per cell basis in CD8
+perforin
+ (right, square symbols) and CD8
+IL2
+ (left, circle symbols) T cells after SEB stimulation.
Observations are paired and colour-coded by subject. Statistical difference determined by a Paired t test, two-tailed, t=5.044, df=5.
doi:10.1371/journal.ppat.1000798.g006
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+ T cells, thereby driving the maintenance of a stable
Ad-specific effector population. In contrast, EBV- and flu-specific
CD8
+ T cells typically produce IL-2 and bear a central memory
phenotype. Since antigen load in the chronic phase of these
infections is low or absent, the responding CD8
+ T cell
populations have likely differentiated to a resting memory state,
where immediate cytotoxic potential is not critical.
An alternative interpretation of our data is that control of some
viruses requires differential functional profiles: a polyfunctional
response led by IL-2 is necessary for EBV and influenza, while
CMV and Adenovirus may need to be controlled or cleared by a
perforin-dominated response. Our phenotypic profiling of the
perforin and IL-2 functional subsets as effector and central
memory-like T cells, respectively, (Supplementary Figure S2) is in
agreement with previous work on CD8
+ T cell maturation, which
included the measurement of pre-formed perforin, to ascribe discrete
functional attributes to specific stages of differentiation[31,33,44,45].
On this basis, several studies have related particular memory
phenotypes to control of certain viral infections[32,34,46,47,48].
Our work elaborates on these earlier studies by correlating specific,
complex functional profiles to immunity against different viral
pathogens, irrespective of stage of differentiation. The D48 perforin
antibody used here enabled the measurement of both pre-formed and
new perforin, permitting a detailed characterization of the complete
perforin compartment and a sharper definition of the mutually
exclusive relationship between the perforin and IL-2 CD8
+ Tc e l l
functional subsets. Given the cross-sectional nature of our study, it is
not possible to ascertain whether new perforin and IL-2 dominated
functional subsets represent stable CD8
+ T cell populations that
actually abrogate their respective viral burdens, or if they are subsets
that result as a consequence to a waning antigenic presence. A
longitudinal analysis of CD8
+ Tc e l l sr e s p o n d i n gt ot h el i v ey e l l o w
fever virus and smallpox vaccines recently showed that both vaccines
generated a primary virus-specific CD8
+ T cell response that passed
through an obligate effector phase in which the cells abundantly
expressed perforin and granzyme B[49]. The cells then differentiated
into long-lived memory cells that maintained the ability to proliferate
and secrete effector cytokines in response to antigen[49]. Thus, the
perforin and IL-2 functional subsets we describe herein likely serve to
mediate protective immunity at different stages of infection.
What is responsible for the transition from a polyfunctional
response highlighted by rapid perforin upregulation to an IL-2-
dominated response? What determines the array of functions a
CD8
+ T cell can perform? Antigen sensitivity has recently been
reported to be required for the development of a polyfunctional
CD8
+ T cell response[50], but the mechanism behind this
phenomenon remains to be elucidated. Our association between
elevated CD28 levels and IL-2 production by antigen-specific
CD8
+ T cells confirms published findings describing a direct role
for CD28 signaling in IL-2 induction[35,36]. Our observation that
new perforin preferentially accumulates in human CD8
+ T cells
that express the transcription factor T-bet supports the role of T-
bet as a ‘master regulator’ of effector CD8
+ T cell responses
[37,38,51,52]. Corollary, the relatively reduced levels of T-bet in
the IL-2 producing CD8
+ T cells supports data from mouse
models of T cell differentiation which demonstrate that T-bet is
also a transcriptional repressor of IL-2[53,54]. Furthermore, T-bet
expression correlates with the development of short-lived effector
cells in mice, whereas a moderate decrease in T-bet expression
promotes long-lived memory [51,52,55]. Thus, our data suggest
that T-bet is intimately involved in determining the functional
capabilities of virus-specific CD8
+ T cells, and provide an
important premise in humans on which to explore the relationship
between T-bet and the perforin gene.
The interplay between IL-2 and perforin thus necessitates a re-
evaluation of our current interpretation of CD8
+ Tc e l lp o l y f u n c t i o n -
ality. The prevailing rationale is that antigen-specific polyfunctional
CD8
+ T cell responses containing IL-2 are most effective at
controlling viral replication[13]; a premise that is driving current T
cell based vaccine strategies. Our data suggest that we need to
reclassify CD8
+T cellpolyfunctionality into at least two distinct types:
polyfunctional memory (IL-2 + IFN-c + other functions without
perforin) or polyfunctional effector (perforin + IFN-c + other
functions without IL-2), each profile being distinct and worthy of
independentconsideration. Inreality, bothfunctionalsubsets willlikely
be required for a protective immune response, each being
instrumental at different stages of infection.
Materials and Methods
Ethics statement
The University of Pennsylvania’s Center for AIDS Research
Human Immunology Core (IRB# 705906), The Wistar Institute
(IRB#2506215), and Duke University (IRB exempt) obtained written,
informed consent from every donor subject in order to collect PBMC
samples and approved the methods employed in this study.
Cells and peptides
PBMC were cryopreserved in fetal bovine serum (FBS; ICS
Hyclone, Logan, Utah) containing 10% dimethyl sulfoxide
(DMSO; Fisher Scientific, Pittsburgh, Pennsylvania). Individual
peptide stimuli were determined by prior epitope mapping by
IFN-c Elispot experiments. In subjects for whom epitopes were not
identified, pools of peptides (15mers overlapping by 11 amino
acids) were used. Regarding the use of 15 versus 9 amino acid
individual peptides, several studies have shown that although some
variation in function and magnitude can be present between some
epitopes, on average the magnitude and functionality of responses
to CTL epitopes represented as a 9 mer or within a 15 mer peptide
are generally equivalent. As a proof of concept, we stimulated
Subject E with both an optimal and a 15 amino acid peptide
containing the epitope TPRVTGGGA and quantified very similar
responses (Supplemental Figure S3).
Antibodies
Antibodies for surface staining included anti-CD4 PE Cy5-5
(Invitrogen; Carlsbad, California), anti-CD107a FITC (BD
Biosciences; San Jose, California), anti-CD8 Qdot 655 (custom)
or TRPE (Invitrogen; Carlsbad, California), anti-CD14 Pac Blue
(BD Biosciences; San Jose, California), anti-CD16 Pac Blue (BD
Biosciences; San Jose, California), and anti-CD19 Pac Blue
(Invitrogen; Carlsbad, California), anti-CD57 Qdot 565 (custom),
anti-CD27 PE Cy5 (Beckman Coulter, Inc; Fullerton, California)
or PerCP Cy5-5 (Biolegend; San Diego, California), anti-CD28
ECD (Beckman Coulter, Inc; Fullerton, California) and anti-
CD45RO Qdot 605/705 (custom) or ECD (Beckman Coulter,
Inc; Fullerton, California). Antibodies for intracellular staining
included anti-CD3 Qdot 585 (custom), anti-Granzyme B Texas
Red PE (BD Pharmingen; San Diego, California), anti-IFN-c
Alexa 700 (BD Pharmingen; San Diego, California), anti-IL-2
APC (BD Pharmingen; San Diego, California), anti-TNF-a PE
Cy7 (BD Biosciences; San Jose, California), and anti-T-bet (Santa
Cruz Biotechnology; Santa Cruz, California). Custom conjuga-
tions to Quantum (Q) dot nanocrystals were performed in our
laboratory as previously described[56], with reagents purchased
from Invitrogen (Carlsbad, California). Anti-human perforin
antibodies were purchased from Tepnel (clone D48, Besancon,
France) and BD Biosciences (clone dG9, San Jose, California).
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Cryopreserved PBMC were thawed, and then rested overnight at
37uC, 5% CO2 in complete medium [RPMI (Mediatech Inc;
Manassas, Virginia) supplemented with 10% FBS, 1% L-glutamine
(Mediatech Inc; Manassas, Virginia), and 1% penicillin-streptomycin
(Lonza; Walkersville, Maryland), sterile filtered] at a concentration of
2610
6 cells per ml medium in 12-well plates. The next day, the cells
were washed with complete medium and resuspended at a
concentration of 1610
6 cells/ml with costimulatory antibodies
(anti-CD28 and anti-CD49d; 1 mg/ml final concentration; BD
Biosciences; San Jose, California), in the presence of monensin
(0.7 mg/ml final concentration; BD Biosciences; San Jose, California)
and brefeldin A (1 mg/ml final concentration; Sigma-Aldrich; St.
L o u i s ,M i s s o u r i ) .A n t i - C D 1 0 7 aw a sa l w a y sa d d e da tt h es t a r to fa l l
stimulation periods, as described previously[29]. As a negative
control, 5 ml of DMSO was added to the cells, an equivalent
concentration compared to the peptide stimulus. SEB served as the
positive control (1 mg/ml final concentration; Sigma-Aldrich; St.
Louis, Missouri). Peptide stimulations were performed at a final
concentration of 2 mM. Stimulation tubes were incubated at 37uC,
5% CO2 for six hours, after which cells were washed once with PBS
and then stained for viability with Aqua amine-reactive viability dye
(Invitrogen; Carlsbad, California) for ten minutes in the dark at room
temperature. A cocktail of antibodies was then added to the cells to
stain for surface markers for an additional twenty minutes. The cells
were washed with PBS containing 1% bovine serum albumin (BSA,
Fisher Scientific; Pittsburgh, Pennsylvania) and 0.1% sodium azide
(Fisher Scientific; Pittsburgh, Pennsylvania), and permeabilized using
the Cytofix/Cytoperm kit (BD Biosciences; San Jose, California)
according to the manufacturer’s instructions. A cocktail of antibodies
against intracellular markers was then added to the cells and allowed
to incubate for one hour in the dark at room temperature. The cells
were then washed once with Perm Wash buffer (BD Biosciences; San
Jose, California) and fixed in PBS containing 1% paraformaldehyde
(Sigma-Aldrich; St. Louis, Missouri). Fixed cells were stored in the
dark at 4uC until the time of collection.
Flow cytometric analysis
For each specimen, between 500,000 and 1,000,000 total events
were acquired on a modified flow cytometer (LSRII; BD Immuno-
cytometry Systems; San Jose, California) equipped for the detection of
18 fluorescent parameters. Antibody capture beads (BD Biosciences;
San Jose, California) were used to prepare individual compensation
tubes for each antibody used in the experiment. Data analysis was
performed using FlowJo version 8.7.3 (TreeStar, Ashland, Oregon).
Reported data have been corrected for background.
Figures
Canvas software, version 10.4.9 (ACD Systems; Miami,
Florida), and Prism software, version 5.0 (Graphpad; La Jolla,
California), were used to create the figures. Labels and boxes were
added to raw data images in Canvas. The dots for Subject C in the
bottom right panel of Figure 6 were enlarged in Canvas to
facilitate visual identification and discrimination.
Statistical analyses
Correlation between %IL-2 and %perforin of IFN-c producing
CD8
+ T cells was determined by a two-tailed Pearson correlation
test. A two-tailed Paired t-test was used to define statistically
significant differences in CD28 and T-bet expression between IL-2
and perforin producing CD8
+ T cells. Both analyses were
performed using Prism software.
Supporting Information
Figure S1 Differential Expression of CD28 on IL-2 and Perforin
Upregulating CD8
+ T cells. Donor PBMC were stimulated for
6 hours with peptide and/or SEB to induce perforin and IL-2
upregulation in order to assess the patterns of CD27, CD28, and
CD57 expression on the activated cells. Shown above are 2
representative examples: Donor 317 developed a robust perforin
response whereas Donor 232 mounted a strong IL-2 response as a
result of SEB stimulation. For each subject, the dot plot on the left
illustrates the total perforin or IL-2 response by the complete
CD8
+ T cell compartment, whereas the smaller dot plots on the
right illustrate the expression of the cell surface markers on the
responding (boxed) populations.
Found at: doi:10.1371/journal.ppat.1000798.s001 (0.16 MB PDF)
Figure S2 IL-2 and Perforin Upregulating CD8
+ T cells Bear
Different Memory Phenotypes. Top row: EBV peptide 19 specific
response by Subject V. The dot plot on the left illustrates the
distribution of all functional cells (blue dots), irrespective of
function, among the entire CD8
+ T cell population (black density
plots), separated according to CD27 and CD45RO, whereas the
blue dots in the right panel signify only IL-2 producing cells.
Middle row: CMV peptide 21 specific response by Subject E. Left
overlay dot plot shows all responding CD8
+ T cells (red dots)
whereas the right plot displays only perforin-upregulating cells (red
dots). Bottom row: CMV peptide 21 specific response by Subject
C. Left overlay dot plot illustrates the distribution of all responding
CD8
+ T cells (red dots) across the entire CD8
+ T cell population
(grey density plots), separated according to CD27 and CD45RO.
The right plot displays both the IL-2 producing (blue dots) and
perforin-upregulating (red dots) cells. The dots were enlarged to
facilitate visual identification and discrimination.
Found at: doi:10.1371/journal.ppat.1000798.s002 (0.20 MB PDF)
Figure S3 The optimal peptide and the 15 amino acid peptide
stimulate similar reponses. Donor E PBMC were stimulated for
6 hours with either the optimal length peptide representing the
CMV pp65 epitope TPRVTGGGA or the longer 15 amino acid
peptide that includes the CMV pp65 epitope: RKTPRVTGGGA-
MAGA. As illustrated above, both peptides induced similar IFN-c,
IL-2, and perforin repsonses from the CD8
+ T cell compartment.
Found at: doi:10.1371/journal.ppat.1000798.s003 (0.19 MB PDF)
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